MedTrace Logo

The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver

NCT03319199 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2019-08-09

No results posted yet for this study

Summary

L-carnitine is an amino acid that is naturally produced in the liver and kidneys, it is involved in transporting fatty acids across the mitochondrial membrane, it could be an important component in treating a fatty liver disease.

The investigators conduct a study to evaluate the efficacy of the combination of L-Carnitine and Magnesium as a treatment for fatty liver.

Conditions

  • Fatty Liver, Nonalcoholic

Interventions

DIETARY_SUPPLEMENT

"SLIM WATER"

2 grams of L- CARNITINE and 150 mg MAGNESIUM for a duration of 16 weeks

OTHER

Placebo - water

for a duration of 16 weeks

Sponsors & Collaborators

  • HaEmek Medical Center, Israel

    collaborator OTHER

  • Rawi Hazzan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-30
Primary Completion
2018-01-10
Completion
2018-07-25

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03319199 on ClinicalTrials.gov